拓维创新生物科技（香港）有限公司 Tavotek Biotherapeutics (Hong Kong) Limited
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Tavotek Biotherapeutics Announces Completion of Round A1 and A2 Financing with over $20 Million Dollars 2021-03-22 19:00
Tavotek Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies using Genmab's DuoBody® Platform against a Pair of Disease Relevant Targets 2020-05-25 22:00
1